title: Might ezetimibe be considered an expensive placebo?
authors.affiliation: Comando Brigata Alpina "Julia"/Multinational Land Force, Medical Service, 8 Via S. Agostino, Udine 33100, Italy. Electronic address: lumasci@libero.it.
authors.forename: Luca
authors.initials: L
authors.lastname: Mascitelli
authors.affiliation: NCH Physician Group, 1845 Veterans Park Drive, Suite 110, Naples, FL 34109, USA. Electronic address: markrgoldstein@comcast.net.
authors.forename: Mark R
authors.initials: MR
authors.lastname: Goldstein
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D000069438:Ezetimibe / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D008055:Lipids / Q000097:blood; D015990:Placebo Effect; D016896:Treatment Outcome
chemical_list: D008055:Lipids; D000069438:Ezetimibe
keywords: Cardiovascular events; Cholesterol; Ezetimibe; Statins